Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2015
At a glance
- Drugs Antiretrovirals
- Indications HIV infections
- Focus Biomarker; Therapeutic Use
- Acronyms COAT
- 06 Mar 2013 Primary endpoint results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 06 Mar 2013 This study was halted early by the Data and Safety Monitoring Board due to a substantial excess 6-month mortality in the early ART group.
- 06 Mar 2013 Biomarker results presented at the 20th Conference on Retroviruses and Opportunistic Infections.